oct 17, 2014 - FDA approved new labeling for Embeda
(morphine sulfate and naltrexone hydrochloride),
an extended-release (ER) opioid analgesic to treat
pain severe enough to require daily, around-the-
clock, long-term opioid treatment and for which
alternative treatment options are inadequate.
Added to timeline:
Opioids and the FDA
Date:
